Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy
NCT06534957
Summary
The goal of this prospective, waitlist-controlled, 1:1 randomized study is to evaluate if an online mindfulness-based stress reduction (MBSR) intervention reduces treatment-related stress levels among patients with breast cancer receiving chemotherapy. The main questions it aims to answer are: * Does an online MBSR intervention reduce stress levels (measured through the Perceived Stress Scale) among participants? * Does an online MBSR intervention reduce anxiety, depression, insomnia, fatigue, nausea, diarrhea, constipation, pain, and peripheral neuropathy (measured through the PRO-CTCAE of the National Cancer Institute) among participants? Researchers will compare the online MBSR intervention to no intervention to see if online MBSR reduces treatment-related stress. Participants will: * Participate in an online MBSR intervention or no intervention for 6 weeks * Answer the study surveys at baseline, 7 weeks, and 11 weeks of follow-up
Eligibility
Inclusion Criteria: * Female sex * Age ≥18 years * Diagnosis of non-metastatic breast cancer * Plan to start neoadjuvant or adjuvant chemotherapy in \<4 weeks * Internet access at home or in their mobile phone * Availability to participate in the online MBSR intervention for 6 weeks * Availability to answer the study surveys * Provision of signed informed consent Exclusion Criteria: * Disease recurrence * Current meditation or mindfulness practice * Inability to read or write
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06534957